SAN DIEGO CALIFORNIA, August 4, 2022 — GBT Technologies Inc. (OTC: GTCH) (the “Company”), a technology company focused on developing a portfolio of Intellectual Property targeted on integrated circuits design automation, IoT (Internet of Things), mesh radio technology and Artificial Intelligence (AI), today announced that on August 1, 2022, the Company and GTX Corp (OTC: GTXO) (“GTX”), a pioneer in the fields of health & safety GPS wearables, human & asset tracking systems, and personal protective medical equipment supplies, entered into a second Letter of Intent (“LOI”) (the initial LOI was signed on June 10, 2021). The second LOI establishes a mutual path to evaluate the viability and market size of the Company’s Intellectual Property (IP) with the goal of the parties to enter a worldwide exclusive licensing agreement for GTX to manufacture, sell and distribute GBT’s products. The main focus is aimed on the qTerm – an AI driven, human vital sign device (https://qterm.me).
“We believe this proposed relationship with GTX can improve our go to market efforts for our qTerm device particularly as i tis our first fully developed commercial release. GTX’s proven extensive global reach, experience in getting innovative products to market, and deep understanding of our technologies, were critical factors in our decision to enter into this letter of intent, which potentially may lead into a formal license agreement.” stated the Company’s Chief Technology Officer, Danny Rittman.
Patrick Bertagna, GTX Chief Executive Officer, stated “My team and I are excited to have the opportunity to expand our product line and capabilities with GBT’s qTerm as well as exploring other products in the GBT portfolio. I believe that qTerm, an intelligent, human vital sign monitoring device, has the capability to enhance our existing offerings to our global customers and distribution partners.”
Any relationship between the parties as contemplated by the LOI is subject to the parties, finalizing due diligence, and entering into a material definitive agreement approved by each parties Board of Directors on or before December 31st 2022.
About GBT
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Contact:
Mansour Khatib, CEO
press@gopherprotocol.com
MetAlert (OTC: MLRT) and its subsidiary Level 2 Security occupy a commanding position in the design, development, manufacturing, distribution, sales, and IP licensing of GPS wearable technology, firearm and mobile asset recovery solutions, remote patient monitoring technology, and health data collection. With years of industry expertise and a robust portfolio of patents, MetAlert is the go-to solution provider for government, enterprise and consumers grappling with mobility, cognitive, and spatial awareness challenges, which currently represents approximately 2.9% of the global population. The Company delivers comprehensive turnkey solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. And MyGunAlert the first patented lockable, motion sensitive, firearm recovery device supported by law enforcement.
MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private and public educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises. Recognizing its capacity within its distribution center and backend subscription processing also presents an opportunity to provide backend services for other subscription based enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.